227 related articles for article (PubMed ID: 15529621)
1. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glucose metabolism in patients treated with antipsychotics.
Scheen AJ; De Hert MA
Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
4. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
5. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
7. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
Meltzer HY
J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
[TBL] [Abstract][Full Text] [Related]
8. Metabolic studies of atypical antipsychotic agents and diabetes.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):72-9. PubMed ID: 19667654
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes mellitus type II--induced by "atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):312-22. PubMed ID: 12796851
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
11. [Atypical antipsychotic induced weight gain and metabolic disorders].
Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
[TBL] [Abstract][Full Text] [Related]
12. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
14. Relationship of atypical antipsychotics with development of diabetes mellitus.
Citrome LL; Jaffe AB
Ann Pharmacother; 2003 Dec; 37(12):1849-57. PubMed ID: 14632602
[TBL] [Abstract][Full Text] [Related]
15. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
Dufresne RL
Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
[TBL] [Abstract][Full Text] [Related]
16. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
17. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
20. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
